DraftKings’ bulls were thrown an unexpected curveball, but this new competition doesn’t carry the same brand-name cache. After years of development, Recursion Pharmaceuticals’ AI-powered drug discovery technology should finally, firmly start proving its true value.
Source: https://www.fool.com/investing/2026/01/29/forget-2025-these-…
Non-U.S. stocks look poised for another standout year, fueled by rising earnings and falling interest rates. Where to shop now.
Eli Lilly is a top healthcare company that’s not only generating impressive growth right now, but continuing to invest in its future. American Express’ strong brand and clientele make it a resilient financial stock to invest in for the long haul.
If a recession were to hit, it’s a foregone conclusion that people won’t stop taking their prescriptions, and they won’t cancel major medical treatments.
